Clinical Trials in Boston

Showing 5441-5460 of 17,836 trials

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

NCT03533257

The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD).

Alzheimer Disease

Amylyx Pharmaceuticals Inc.95 participantsStarted Sep 2018

Jacksonville, Florida, United States • Orlando, Florida, United States • Palmetto Bay, Florida, United States +8 more locations

COMPLETED< 1 mile

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

NCT04950712

The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.

Herpes Genitalis

GlaxoSmithKline537 participantsStarted Jun 2021

Long Beach, California, United States • Los Angeles, California, United States • San Francisco, California, United States +48 more locations

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Find Trials by Condition in Boston

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

The MIRIA Acne Scar Study

IMPRINT VR Trainer Evaluation

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

A Study Evaluating ANV600 Single Agent or in Combination with Pembrolizumab in Participants with Advanced Solid Tumors (EXPAND-1)

CorPath® GRX Neuro Study

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy